Chronic Kidney Disease: Screening
The results below represent 432,901 patients with diabetes or hypertension who do not have chronic kidney disease or end-stage renal disease. Read More About This Measure
Within the past decades there has been increasing evidence that the adverse outcomes of chronic kidney disease such as kidney failure, heart disease, and premature death can be prevented or delayed. Earlier stages of chronic kidney disease can be detected through laboratory testing. Screening asymptomatic individuals at increased risk could allow earlier detection of chronic kidney disease.
Disclaimer: Measures reported by WCHQ healthcare
organizations represent a specific aspect of care in relation to an
evidence-based standard, but are not clinical guidelines and do not establish
standards of care.
This measure assesses the percentage of patients age 18 to 85 years of age with either diabetes or hypertension excluding those with chronic kidney disease (CKD) and end stage renal disease (ESRD) who had an Estimated Glomerular Filtration Rate (eGFR) test during the 12-month measurement period.